Urogenital Neoplasms: all 135 studies
Page 2 of 2. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About CancerActive, not recruitingNCT03794635Not applicable
- Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCompletedNCT03562897Phase 2
- Potential Therapeutic Response In Urogenital TumorsCompletedNCT03551457
- Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsActive, not recruitingNCT03333616Phase 2
- Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) CancersTerminatedNCT03134027
- PROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerActive, not recruitingNCT02735252Not applicable
- The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal SurgeryCompletedNCT02728921Phase 4
- 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsTerminatedNCT02602067Phase 1
- Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)CompletedNCT02583815
- A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerTerminatedNCT02543645Phase 1
- Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsActive, not recruitingNCT02496208Phase 1
- Guided Imagery in the Perioperative Period in Gynecologic Oncology PatientsCompletedNCT02444195Not applicable
- A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaTerminatedNCT02386111Phase 1
- A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion CohortsActive, not recruitingNCT02266745Phase 2
- SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study IWithdrawnNCT02254915Phase 3
- A Feasibility Trial of Geriatric Assessment and Management for Older Cancer PatientsCompletedNCT02222259Not applicable
- Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)CompletedNCT02140463
- Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare CancerCompletedNCT02067754
- Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1RCompletedNCT02045368Phase 1
- RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)TerminatedNCT02026960Not applicable
- Protection of Rectum From High Radiation Doses Using a SpacerTerminatedNCT01918605Not applicable
- Rapid Autopsy and Procurement of Cancer TissueTerminatedNCT01851395
- Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsCompletedNCT01639911Phase 1
- Assessing the Patient Experience in Cancer CareCompletedNCT01621295
- Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological PatientsCompletedNCT01523652
- Integrated Molecular Profiling in Advanced Cancers TrialActive, not recruitingNCT01505400
- Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous BypassCompletedNCT01433302
- Acupuncture for the Immune System in Radiation Cancer PatientsWithdrawnNCT01422928Phase 3
- Alkagin Paste in the Prevention of Radiation DermatitisTerminatedNCT01408407Phase 2
- Doxorubicin With or Without Sildenafil, With Analysis of Cardiac MarkersCompletedNCT01375699Phase 1
- Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyCompletedNCT01316458Phase 2
- Study of Abiraterone Acetate in Patients With Advanced Prostate CancerApproved for marketingNCT01217697
- A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerTerminatedNCT00672009Phase 2
- Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) CancerCompletedNCT00134186Phase 2
- Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial CarcinomaCompletedNCT00050440Phase 2